Heidi Moore

All articles by Heidi Moore

ACAAI 2020

Crisaborole Safe, Efficacious in Atopic Dermatitis, With or Without Allergic Rhinitis

Heidi Moore

November 17, 2020

The safety and efficacy of crisaborole ointment, 2%, was examined in pediatric patients with mild to moderate atopic dermatitis with and without comorbid allergic rhinitis.

AAAAI 2020

Long-Term Crisaborole May Be Necessary to Control Atopic Dermatitis Symptoms

Heidi Moore

March 13, 2020

Repeated cycles of treatment with crisaborole may be necessary to achieve and maintain control of atopic dermatitis symptoms.

CHEST 2019

Aspergillosis, ABPA-Related Hospitalizations in Cystic Fibrosis Confer Worse Outcomes

Heidi Moore

October 19, 2019

Nearly one-third of patients with cystic fibrosis-related hospitalizations have aspergillosis, which is associated with worse outcomes.

Next post in CHEST 2019

Heidi Moore

All articles by Heidi Moore

Crisaborole Safe, Efficacious in Atopic Dermatitis, With or Without Allergic Rhinitis

Long-Term Crisaborole May Be Necessary to Control Atopic Dermatitis Symptoms

Aspergillosis, ABPA-Related Hospitalizations in Cystic Fibrosis Confer Worse Outcomes

Asthma, COPD, and Asthma-COPD Overlap Differentiated Using Sputum Cell Count